The mutational spectrum in a cohort of Charcot-Marie-Tooth disease type 2 among the han Chinese in Taiwan

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Lin, Kon Ping ^a,b   Soong, Bing Wen ^a,b   Yang, Chih Chao ^c   Huang, Li Wen ^a,b   Chang, Ming Hong ^a,d   Lee, I Hui ^a   Antonellis, Antony ^e   Lee, Yi Chung ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

AARS GENE; ADOLESCENT; ADULT; ARTICLE; ASIAN; CHARCOT MARIE TOOTH DISEASE TYPE 2; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; DNM2 GENE; FEMALE; GARS GENE; GDAP1 GENE; GENE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HAN CHINESE; HEREDITARY MOTOR SENSORY NEUROPATHY; HSPB1 GENE; HSPB8 GENE; HUMAN; IN VITRO STUDY; MALE; MFN2 GENE; MOLECULAR PATHOLOGY; MPZ GENE; MUTATION RATE; MUTATIONAL ANALYSIS; NEFL GENE; PRESCHOOL CHILD; RAB7 GENE; RNA SPLICING; TAIWAN; TAIWANESE; TRPV4 GENE; YARS GENE; AMINO ACID SEQUENCE; ANIMAL; CATTLE; ETHNIC GROUP; ETHNOLOGY; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; MOUSE; MUTATION; NUCLEOTIDE SEQUENCE; RAT;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANIMALS; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CATTLE; CHARCOT-MARIE-TOOTH DISEASE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; RATS; TAIWAN; YOUNG ADULT;

EID: 83655212414     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029393     Document Type: Article

References (45)

1. Klein CJ, Dyck PJ, (2005) HMSN II (CMT2) and miscellaneous inherited system atrophies of nerve axon: clinical-molecular genetic correlates. In: Dyck PJ, Thomas PK, editors. Peripheral Neuropathy, 4rd ed Philadelphia Elsevier Saunders pp. 1094-1136.
2. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, et al. (2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1B-beta. Cell 105: 587-597.
3. Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, et al. (2004) Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nature Genet 36: 449-451.
4. Verhoeven K, De Jonghe P, Coen K, Verpoorten N, Auer-Grumbach M, et al. (2003) Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 72: 722-727.
5. Landoure G, Zdebik AA, Martinez TL, Burnett BG, Stanescu HC, et al. (2010) Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet 42: 170-174.
6. Antonellis A, Ellsworth RE, Sambuughin N, Puls I, Abel A, et al. (2003) Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 72: 1293-1299.
7. Mersiyanova IV, Perepelov AV, Polyakov AV, Sitnikov VF, Dadali EL, et al. (2000) A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-like gene. Am J Hum Genet 67: 37-46.
8. Evgrafov OV, Mersiyanova I, Irobi J, Van Den Bosch L, Dierick I, et al. (2004) Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nature Genet 36: 602-606.
9. Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, et al. (1998) Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 50: 1397-1401.
10. De Jonghe P, Timmerman V, Ceuterick C, Nelis E, De Vriendt E, et al. (1999) The thr124-to-met mutation in peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 122: 281-290.
11. Claramunt R, Pedrola L, Sevilla T, López de Munain A, et al. (2005) Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect. J Med Genet 42: 358-365.
12. Cuesta A, Pedrola L, Sevilla T, García-Planells J, Chumillas MJ, et al. (2002) The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 30: 22-24.
13. Irobi J, Van Impe K, Seeman P, Jordanova A, Dierick I, et al. (2004) Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet 36: 597-601.
14. Tang B, Zhao G, Luo W, (2005) Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet 116: 222-224.
15. Fabrizi GM, Ferrarini M, Cavallaro T, Cabrini I, Cerini R, et al. (2007) Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. Neurology 69: 291-295.
16. Latour P, Thauvin-Robinet C, Baudelet-Mery C, Soichot P, Cusin V, et al. (2010) A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alany-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet 86: 77-82.
17. De Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat JM, Tazir M, et al. (2002) Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 70: 726-736.
18. Leal A, Huehne K, Bauer F, Sticht H, Berger P, et al. (2009) Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models. Neurogenetics 10: 275-287.
19. Verhoeven K, Claeys KG, Zuchner S, Schröder JM, Weis J, et al. (2006) MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 129: 2093-2102.
20. Chung KW, Kim SB, Park KD, Choi KG, Lee JH, et al. (2006) Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 129: 2103-2118.
21. Calvo J, Funalot B, Ouvrier RA, Lazaro L, Toutain A, et al. (2009) Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations. Arch Neurol 66: 1511-1516.
22. Feely SME, Laura M, Siskind CE, Sottile S, Davis M, et al. (2011) MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology 76: 1690-1696.
23. Zuchner S, Noureddine M, Kennerson M, Verhoeven K, Claeys K, et al. (2005) Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet 37: 289-294.
24. Jordanova A, Irobi J, Thomas FP, Van Dijck P, Meerschaert K, et al. (2006) Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 38: 197-202.
25. Mastaglia FL, Nowak KJ, Stell R, Phillips BA, Edmondston JE, et al. (1999) Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry 67: 174-179.
26. De Jonghe P, Timmerman V, Van Broeckhoven C, (1998) 2nd Workshop of the European CMT Consortium: 53rd ENMC International Workshop on Classification and Diagnostic Guidelines for Charcot-Marie-Tooth Type 2 (CMT2-HMSN II) and Distal Hereditary Motor Neuropathy (distal HMN-Spinal CMT) 26-28 September 1997, Naarden, The Netherlands. Neuromuscul Disord 8: 426-431.
27. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
28. Boaretto F, Vettori A, Casarin A, Vazza G, Muglia M, et al. (2010) Severe CMT type 2 with fatal encephalopathy associated with a novel MFN2 splicing mutation. Neurology 74: 1919-1921.
29. McLaughlin HM, Sakaguchi R, Liu C, Igarashi T, Pehlivan D, et al. (2010) Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. Am J Hum Genet 87: 560-566.
30. Haslbeck M, Franzmann T, Weinfurtner D, Buchner J, (2005) Some like it hot: the structure and function of small heat-shock proteins. Nat Struct Mol Biol 12: 842-846.
31. Baranova EV, Weeks SD, Beelen S, Bukach OV, Gusev NB, et al. (2011) Three-dimensional structure of α-crystallin domain dimers of human small heat shock proteins HSPB1 and HSPB6. J Mol Biol 411: 110-122.
32. Houlden H, Laura M, Wavrant-De Vrièze F, Blake J, Wood N, et al. (2008) Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2. Neurology 71: 1660-1668.
33. Almeida-Souza L, Goethals S, de Winter V, Dierick I, Gallardo R, et al. (2010) Increased monomerization of mutant HSPB1 leads to protein hyperactivity in Charcot-Marie-Tooth Neuropathy. J Biol Chem 285: 12778-12786.
34. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, et al. (2000) Hsp27 negatively regulates cell death by interacting with cytochrome c. Nature Cell Biol 2: 645-652.
35. Mehlen P, Kretz-Remy C, Preville X, Arrigo AP, (1996) Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNF alpha-induced cell death. EMBO J 15: 2695-2706.
36. Lavoie JN, Hickey E, Weber LA, Landry J, (1993) Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27. J Biol Chem 268: 24210-24214.
37. Niemann A, Ruegg M, La Padula V, Schenone A, Suter U, (2005) Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J Cell Biol 170: 1067-1078.
38. Nelis E, Erdem S, Van den Bergh PYK, Belpaire-Dethiou MC, Ceuterick C, et al. (2002) Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy. Neurology 59: 1865-1872.
39. Shield AJ, Murray TP, Board PG, (2006) Functional characterization of ganglioside-induced differentiation-associated protein 1 as a gluthione transferase. Biochem Biophys Res Commun 347: 859-66.
40. Cassereau J, Chevrollier A, Gueguen N, Desquiret V, Verny C, et al. (2011) Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutations. Exp Neurol 227: 31-41.
41. Züchner S, Vorgerd M, Sindern E, Schröder JM, (2004) The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy. Neuromuscul Disord 12: 147-157.
42. Choi BO, Lee MS, Shin SH, Hwang JH, Choi KG, et al. (2004) Mutational analysis of PMP22, MPZ, GJB1, EGR2, and NEFL in Korean Charcot-Marie-Tooth neuropathy patients. Hum Mutat 24: 185-186.
43. Abe A, Numakura C, Saito K, Koide H, Oka N, et al. (2009) Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype. J Hum Genet 54: 94-97.
44. Cooper DN, Youssoufian H, (1988) The CpG dinucleotide and human genetic disease. Hum Genet 78: 151-155.
45. Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, et al. (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64: 1209-1214.